Affiliation:
1. Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Takamatsu 761-0793, Kagawa, Japan
Abstract
Vascular invasion of hepatocellular carcinoma involves tumor plugs in the main trunk of the portal vein, bile ducts, and veins, and it indicates poor prognosis. It is often associated with portal hypertension, which requires evaluation and management. Treatment includes hepatic resection, systemic pharmacotherapy, hepatic arterial infusion chemotherapy, and radiation therapy. Recurrence rates post-hepatic resection are high, and systemic drug therapy often has limited therapeutic potential in patients with a poor hepatic reserve. Single therapies are generally inadequate, necessitating combining multiple therapies with adjuvant and systemic pharmacotherapy before and after hepatectomy. This narrative review will provide an overview of the treatment of hepatocellular carcinoma with vascular invasion.
Reference89 articles.
1. Hepatocellular carcinoma;Llovet;Nat. Rev. Dis. Primers,2021
2. AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma;Singal;Hepatology,2023
3. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int. J. Cancer,2015
4. Dalzell, C.G., Taylor, A.C., and White, S.B. (2023). New Insights on Liver-Directed Therapies in Hepatocellular Carcinoma. Cancers, 15.
5. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series;Hardwigsen;J. Gastrointest. Surg.,2006